BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Prognosis
35 results:

  • 1. Development and External Validation of a Nomogram Including Body Composition Parameters for Predicting Early Recurrence of Hepatocellular Carcinoma After Hepatectomy.
    Shi S; Zhao YX; Fan JL; Chang LY; Yu DX
    Acad Radiol; 2023 Dec; 30(12):2940-2953. PubMed ID: 37798207
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Multiple Roles of the RUNX Gene Family in Hepatocellular Carcinoma and Their Potential Clinical Implications.
    Krajnović M; Kožik B; Božović A; Jovanović-Ćupić S
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759525
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Systemic therapy with or without transcatheter intra-arterial therapies for unresectable hepatocellular carcinoma: a real-world, multi-center study.
    Pan Y; Zhu X; Liu J; Zhong J; Zhang W; Shen S; Jin R; Liu H; Ye F; Hu K; Xu D; Zhang Y; Chen Z; Xing B; Zhou L; Chen Y; Zeng Y; Liang X; Kuang M; Song T; Xiang B; Wang K; Sun H; Xu L;
    Front Immunol; 2023; 14():1138355. PubMed ID: 37180173
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A nomogram for predicting overall survival in patients with endometrial carcinoma: A SEER-based study.
    Li R; Yue Q
    Int J Gynaecol Obstet; 2023 Jun; 161(3):744-750. PubMed ID: 36394432
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [The clinical value of classification of hilar cholangiocarcinoma based on actual anatomy].
    Peng SY; Liu YB; Li XS; Wu Y; Jin YQ; Yu XA; Wang W; Gong W
    Zhonghua Wai Ke Za Zhi; 2022 Sep; 60(9):860-865. PubMed ID: 36058713
    [No Abstract]    [Full Text] [Related]  

  • 6. Prognostic value of inflammation-immunity-nutrition score in patients with hepatocellular carcinoma treated with anti-PD-1 therapy.
    Zhang Z; Liang Y; Zhong D; Dai Z; Shang J; Lai C; Zou H; Yao Y; Feng T; Huang X
    J Clin Lab Anal; 2022 May; 36(5):e24336. PubMed ID: 35312116
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Systemic metastases from low-grade and high-grade pseudomyxoma peritonei: Treatments and outcomes.
    Baratti D; Milito P; Kusamura S; Martin Roman L; Guaglio M; Deraco M
    Eur J Surg Oncol; 2022 Jul; 48(7):1590-1597. PubMed ID: 35090796
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical Impact of Primary Tumor Site in Stage IV Colorectal cancer: A Statewide Cohort Study.
    Kawamura H; Honda M; Takiguchi K; Kamiga T; Saito K; Muto A; Shiraso S; Yamashita N; Iwao T; Saji S; Kono K; Konno S
    Anticancer Res; 2021 Nov; 41(11):5693-5702. PubMed ID: 34732442
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical features of patients with HER2-positive breast cancer and development of a nomogram for predicting survival.
    Fan Y; Wang Y; He L; Imani S; Wen Q
    ESMO Open; 2021 Aug; 6(4):100232. PubMed ID: 34392135
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Role of Palliative Care in the Introduction of Chemotherapy in Patients with Poor Performance Status].
    Sato I; Nakaya N; Obara Y; Kurosaka N; Ueno S; Nakajima H
    Gan To Kagaku Ryoho; 2021 May; 48(5):735-737. PubMed ID: 34006726
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.
    Kong C; Zhao Z; Chen W; Lv X; Shu G; Ye M; Song J; Ying X; Weng Q; Weng W; Fang S; Chen M; Tu J; Ji J
    Eur Radiol; 2021 Oct; 31(10):7500-7511. PubMed ID: 33860832
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic cancer.
    Goldstein D; Von Hoff DD; Chiorean EG; Reni M; Tabernero J; Ramanathan RK; Botteman M; Aly A; Margunato-Debay S; Lu B; Louis CU; McGovern D; Lee CK
    Pancreas; 2020 Jul; 49(6):744-750. PubMed ID: 32541630
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. LncRNA runx1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells.
    Sun L; Wang L; Chen T; Shi Y; Yao B; Liu Z; Wang Y; Li Q; Liu R; Niu Y; Tu K; Liu Q
    Cell Death Dis; 2020 Feb; 11(2):95. PubMed ID: 32024815
    [TBL] [Abstract] [Full Text] [Related]  

  • 14.
    Garcia-Carbonero N; Martinez-Useros J; Li W; Orta A; Perez N; Carames C; Hernandez T; Moreno I; Serrano G; Garcia-Foncillas J
    Cells; 2020 Jan; 9(1):. PubMed ID: 31952366
    [No Abstract]    [Full Text] [Related]  

  • 15. LncRNA runx1-IT1 inhibits proliferation and promotes apoptosis of hepatocellular carcinoma by regulating MAPK pathways.
    Yan PH; Wang L; Chen H; Yu FQ; Guo L; Liu Y; Zhang WJ; Bai YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8287-8294. PubMed ID: 31646558
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Noninvasive prediction of HCC with progenitor phenotype based on gadoxetic acid-enhanced MRI.
    Chen J; Wu Z; Xia C; Jiang H; Liu X; Duan T; Cao L; Ye Z; Zhang Z; Ma L; Song B; Shi Y
    Eur Radiol; 2020 Feb; 30(2):1232-1242. PubMed ID: 31529254
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Down-regulation of lncRNA-NEF indicates poor prognosis in intrahepatic cholangiocarcinoma.
    Liang Z; Zhu B; Meng D; Shen X; Li X; Wang Z; Li L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015363
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Immunohistochemical Expression of Epidermal Growth Factor Receptor in Hepatocellular Carcinoma.
    Nikolova D; Chalovska V; Ivanova MG; Nikolovska E; Volkanovska A; Orovchanec N; Kunovska SK; Petrushevska G; Janevska V
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2018 Dec; 39(2-3):21-28. PubMed ID: 30864368
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
    Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
    BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Tumor-to-background ratios of the maximum standardized uptake value could not indicate the prognosis of advanced high-grade serous ovarian cancer patients.
    Liu S; Ju X; Feng Z; Wen H; Xu J; Chen X; Wu X
    Nucl Med Commun; 2018 Apr; 39(4):319-324. PubMed ID: 29533344
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.